| RS886041994 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS886041995 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS886041996 |
STK11
|
Health Risk |
Likely pathogenic |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS886041997 |
CTCF
|
Health Risk |
Pathogenic |
Desmoplastic/nodular medulloblastoma, Alveolar rhabdomyosarcoma |
| RS886041998 |
NEB
|
Health Risk |
Pathogenic |
— |
| RS886041999 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Inborn genetic diseases |
| RS886042000 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Intellectual disability |
| RS886042001 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS886042002 |
PIK3CA
|
Health Risk |
Pathogenic/Likely pathogenic |
Megalencephaly-capillary malformation-polymicrogyria syndrome, Cowden syndrome |
| RS886042003 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS886042004 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS886042005 |
SLC6A8
|
Health Risk |
Pathogenic |
— |
| RS886042006 |
EYA1
|
Health Risk |
Pathogenic |
— |
| RS886042007 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS886042008 |
AGL
|
Health Risk |
Pathogenic |
— |
| RS886042009 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS886042010 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS886042011 |
SALL1
|
Health Risk |
Pathogenic |
— |
| RS886042012 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS886042013 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia 1 |
| RS886042014 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS886042015 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS886042016 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS886042017 |
PURA
|
Health Risk |
Pathogenic |
— |
| RS886042018 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS886042019 |
ANKRD11
|
Health Risk |
Pathogenic/Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS886042020 |
CEP290
|
Health Risk |
Pathogenic |
— |
| RS886042021 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS886042022 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS886042023 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS886042024 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886042025 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886042026 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS886042027 |
POGZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS886042028 |
MOCS1
|
Health Risk |
Pathogenic |
— |
| RS886042029 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS886042030 |
KIT
|
Health Risk |
Pathogenic |
— |
| RS886042031 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS886042032 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS886042033 |
FLCN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS886042034 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886042035 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS886042036 |
ARID1A
|
Health Risk |
Pathogenic |
— |
| RS886042037 |
SH3PXD2B
|
Health Risk |
Pathogenic |
— |
| RS886042038 |
TULP1
|
Health Risk |
Pathogenic |
— |
| RS886042039 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886042041 |
EEF1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS886042043 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886042044 |
FH
|
Health Risk |
Pathogenic |
— |
| RS886042045 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS886042046 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Global developmental delay, Epilepsy with myoclonic atonic seizures |
| RS886042047 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS886042048 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS886042049 |
TBX1
|
Health Risk |
Pathogenic |
— |
| RS886042050 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS886042051 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS886042056 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS886042057 |
GALC
|
Health Risk |
Pathogenic/Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS886042058 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS886042060 |
GALT
|
Health Risk |
Pathogenic |
— |
| RS886042061 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS886042064 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosemia, Galactosemia |
| RS886042066 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS886042070 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Galactosemia |
| RS886042073 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosistype IIIB, Mucopolysaccharidosis |
| RS886042078 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS886042079 |
GLB1
|
Health Risk |
Likely pathogenic |
Infantile GM1 gangliosidosis, Infantile GM1 gangliosidosis |
| RS886042080 |
ACAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS886042084 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS886042086 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS886042087 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS886042088 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS886042089 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS886042091 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS886042092 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Decreased circulating carnitine concentration |
| RS886042093 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy |
| RS886042094 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS886042095 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy |
| RS886042097 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS886042098 |
IVD
|
Health Risk |
Conflicting classifications of pathogenicity |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS886042104 |
ERCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042106 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Dystrophin deficiency |
| RS886042108 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886042109 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS886042110 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886042111 |
MYH3
|
Health Risk |
Likely pathogenic |
— |
| RS886042115 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042116 |
TGM1
|
Health Risk |
Likely pathogenic |
— |
| RS886042120 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Sialuria, GNE myopathy |
| RS886042121 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS886042123 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042124 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042125 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS886042128 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS886042129 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS886042130 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, ALG1-related disorder |
| RS886042132 |
IFT122
|
Health Risk |
Pathogenic |
— |
| RS886042134 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS886042136 |
DYNC2H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS886042140 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |